Skip to main page content

• HOME
• Current Issue
• Archive
• Alerts
• About ASM
• Contact us
• Tech Support
• Journals.ASM.org

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kunimoto, D. Y. Articles by Shafran, S. D. Search for Related Content PubMed PubMed Citation Articles by Kunimoto, D. Y. Articles by Shafran, S. D.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, January 2003, p. 498-499, Vol. 41, No. 1
0095-1137/03/$08.00+0     DOI: 10.1128/JCM.41.1.498-499.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Analysis of Mycobacterium avium Complex Isolates from Blood Samples of AIDS Patients by Pulsed-Field Gel Electrophoresis

D. Y. Kunimoto,^1* M. S. Peppler,² J. Talbot,² P. Phillips,³ S. D. Shafran,¹ and Canadian HIV Trials Network Protocol 010 Study Group

Department of Medicine,¹ Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta,² AIDS Program and Division of Infectious Diseases, St. Paul's Hospital, Vancouver, British Columbia, Canada³

Received 7 February 2002/ Returned for modification 19 June 2002/ Accepted 13 October 2002

Top Abstract Text References

 
A molecular analysis of the first Mycobacterium avium complex (MAC) blood isolates from 177 patients from 10 Canadian cities revealed that each cluster of indistinguishable strains consisted of isolates from epidemiologically unrelated patients in the same city or region. This study supports the premise that acquisition of MAC from a common environmental source occasionally occurs.

Top Abstract Text References

 
Mycobacterium avium complex (MAC) is the commonest cause of systemic bacterial infection in patients with AIDS, with an annual incidence of 20% before the widespread use of highly active antiretroviral therapy (8). The development of disseminated MAC infection produces significant morbidity and is an independent predictor of death (6). MACs are found in water or earth and are usually opportunistic pathogens causing disease in an immunocompromised host. There is no evidence that MAC infection occurs as a result of person-to-person transmission. If such transmission does occur, it would have implications for prophylaxis and other strategies to prevent MAC infection in AIDS patients.

A number of studies have shown that MAC strains can be distinguished by restriction digest and pulsed-field gel electrophoresis (PFGE) (4, 7, 11, 12). Analysis of large DNA restriction fragment (LRF) patterns generated by PFGE of MAC has demonstrated that unrelated strains of MAC are polymorphic whereas strains from the same patient (isolated either from different sites or at different time points) tend to have identical patterns (7). This makes LRF analysis attractive for strain typing of MAC for epidemiological studies. In the present study, the LRF patterns of initial MAC blood isolates (collected for the Canadian HIV Trials Network MAC Treatment trial [10]) of patients were compared to determine the prevalence of clustering of strains in this population and whether there was any evidence of person-to-person transmission.

The Canadian HIV Trials Network MAC Treatment trial was a multicenter collaborative randomized treatment study of AIDS patients with MAC bacteremia (10). Patients were randomized into a treatment protocol after enrollment and monitored with repeat blood cultures at 2, 4, 8, 12, and 16 weeks. A total of 187 patients were eligible for evaluation for the study. All isolates were sent to the Provincial Laboratory of Northern Alberta for species confirmation and susceptibility testing and were stored at -80°C. For this study, coded isolates were grown onto solid media from frozen stock and subcultured from a single colony and a suspension was embedded in an agarose plug. Bacterial cells in the plug were lysed with lysozyme (1 mg/ml final concentration) and RNase (20 mg/ml final concentration) and incubated at 37°C for 4 days. Genomic DNA was digested with AsnI and then subjected to PFGE by the method of Slutsky et al. (11), resulting in LRF patterns. Each PFGE gel incorporated two lanes of lambda ladder molecular mass markers (catalog no. N0340S; New England Biolabs, Missasauga, Ontario, Canada) (range, 48.5 to >1,000 kb). Ethidium bromide-stained images were photographed, printed, and digitalized with the IMAGER video camera system (Appligene, Illkirch, France). Digitalized gel images were analyzed using GelcomparII computer software (Applied Maths, Kortrijk, Belgium). All isolates determined by computer analysis to be indistinguishable or similar were examined by visual comparison of the corresponding lanes on the matched original pictures.

Of 187 MAC initial blood isolates, 2 could not be regrown after frozen storage. Therefore, the remaining 185 initial MAC blood isolates were processed for LRF analysis. Technically acceptable patterns were produced for 177 of the isolates. These 177 coded MAC isolates from 10 Canadian cities were evaluated by blind comparisons of LRF patterns. A representative sample of LRF patterns is shown in Fig. 1. Two or more isolates having indistinguishable patterns were designated a cluster. After identification of clusters, the samples were unblinded and epidemiological data on the patients within clusters were obtained. It was found that patients with isolates belonging to the same cluster were geographically related but not otherwise epidemiologically linked. Of seven clusters that were identified, six consisted of isolates from patients living in the same city as the others with isolates in the same cluster and one consisted of isolates from patients living in cities near those of others with isolates in the same cluster (Table 1). Cluster II consisted of isolates from two patients, one from Montreal and the other from Sherbrooke, a city 150 km away. A numerical simulation by the Monte Carlo method (13) was performed to determine the probability due to chance alone of isolates in clusters being geographically related. The frequency of occurrence due to chance of the isolates in six of the seven clusters originating from patients in the same city would be 8 per 100,000. This would suggest that there is either common source exposure or person-to-person transmission. In this study, there was no suggestion for person-to-person transmission in patients within clusters in that the cases were not epidemiologically closely related. This finding is in keeping with a study by Bauer et al., who reported that when partners had MAC infection, the strains isolated from each partner were different (3).

View larger version (137K): [in this window] [in a new window]

FIG. 1. Sample of LRF patterns of M. avium isolates (lanes 1 to 11). Lanes MW, lambda ladder molecular mass markers (in kilobases).

View this table: [in this window] [in a new window]

TABLE 1. Clustering of isolates by city of origin

Arbiet et al. have demonstrated that 15% of patients may be bacteremic with more than one strain of M. avium simultaneously (1), whereas Picardeau et al. found that less than 5% of patients had polyclonal bacteremia (9). In this study, we chose a single colony and hence a single strain to type by PFGE for each patient. If more than one strain were present, we would miss any additional strains. Therefore, we may have underestimated the number of clusters if patients had another strain which matched the strain of another patient. However, as the colony for each isolate was chosen at random, it is unlikely that the overall conclusions of the study would be affected.

The source of MAC infections is thought to be environmental, with water being an important reservoir. Von Reyn et al. isolated MAC prospectively and found that two clusters of MAC strains from patients were linked to strains isolated from hot water of the hospital that the patients attended (12). Similarly, Aronson et al. described a close relationship between MAC isolates from potable water and clinical isolates (2). Bauer et al. found that some strains of MAC were isolated from patients that were geographically widespread in Denmark and could be found in peat used for potting soil (3). This suggested that peat was the environmental source of MAC, particularly when MAC could not be found in local potable water. Chin et al. have demonstrated that colonization in either lung or stool by MAC correlates with later invasive disease (5). Presumably, MAC is acquired from the environment, colonizing patients and then causing invasive disease, usually when immunity is compromised.

The series of MAC blood isolates employed in the present study is to date the largest to have been analyzed by a DNA typing method, and the results of the analysis lend further support to the premise that MAC is acquired from the environment and that clustering is likely related to common exposure to an environmental source.

 
We are grateful to Ryan Woods for performing the Monte Carlo simulation.

This work was supported by a grant from Pharmacia and Upjohn Canada.

 
* Corresponding author. Mailing address: University of Alberta Hospitals, Department of Medicine, 2F1 WMC, Edmonton, Alberta, T6G 2B7. Phone: 780-407-1418. Fax: 780-407-8256. Email: Dennis.Kunimoto{at}ualberta.ca.

Top Abstract Text References

 

1
1. Arbeit, R. D., A. Slutsky, T. W. Barber, J. N. Maslow, S. Niemczyk, J. O. Falkinham III, G. T. O'Connor, and C. F. von Reyn. 1993. Genetic diversity among strains of Mycobacterium avium causing monoclonal and polyclonal bacteremia in patients with AIDS. J. Infect. Dis. 167:1384-1390.[Medline]
2
2. Aronson, T., A. Holtzman, N. Glover, M. Boian, S. Froman, O. G. W. Berlin, H. Hill, and G. Stelma, Jr. 1999. Comparison of large restriction fragments of Mycobacterium avium isolates recovered from AIDS and non-AIDS patients with those of isolates from potable water. J. Clin. Microbiol. 37:1008-1012.[Abstract/Free Full Text]
3
3. Bauer, J., A. B. Andersen, D. Askgaard, S. B. Giese, and B. Larsen. 1999. Typing of clinical Mycobacterium avium complex strains cultured during a 2-year period in Denmark by using IS1245. J. Clin. Microbiol. 37:600-605.[Abstract/Free Full Text]
4
4. Burki, D. R., C. Bernasconi, T. Bodmer, and A. Telenti. 1995. Evaluation of the relatedness of strains of Mycobacterium avium using pulsed-field gel electrophoresis. Eur. J. Clin. Microbiol. Infect. Dis. 14:212-217.[CrossRef][Medline]
5
5. Chin, D. P., P. C. Hopewell, D. M. Yajko, E. Vittinghoff, C. R. Horsburgh, Jr., W. K. Hadley, E. N. Stone, P. S. Nassos, S. M. Ostroff, M. A. Jacobson, et al. 1994. Mycobacterium avium complex in the respiratory or gastrointestinal tract and the risk of M. avium complex bacteremia in patients with human immunodeficiency virus infection. J. Infect. Dis. 169: 289-295.[Medline]
6
6. Jacobson, M. A., P. C. Hopewell, D. M. Yajko, W. K. Hadley, E. Lazarus, P. K. Mohanty, G. W. Modin, D. W. Feigal, P. S. Cusick, and M. A. Sande. 1991. Natural history of disseminated Mycobacterium avium complex infection in AIDS. J. Infect. Dis. 164:994-998.[Medline]
7
7. Mazurek, G. H., S. Hartman, Y. Zhang, B. A. Brown, J. S. R. Hector, D. Murphy, and R. J. Wallace, Jr. 1993. Large DNA restriction fragment polymorphism in the Mycobacterium avium-M. intracellulare complex: a potential epidemiologic tool. J. Clin. Microbiol. 31:390-394.[Abstract/Free Full Text]
8
8. Nightingale, S. D., D. W. Cameron, F. M. Gordin, P. M. Sullam, D. L. Cohn, R. E. Chaisson, L. J. Eron, P. D. Sparti, B. Bihari, D. L. Kaufman, J. J. Stern, D. D. Pearce, W. G. Weinberg, A. LaMarca, and F. P. Siegal. 1993. Two controlled trials of rifabutin prophylaxis against Mycobacterium avium complex infection in AIDS. N. Engl. J. Med. 329:828-833.[Abstract/Free Full Text]
9
9. Picardeau, M., A. Varnerot, T. Lecompte, F. Brel, T. May, and V. Vincent. 1997. Use of different molecular typing techniques for bacteriological follow-up in a clinical trial with AIDS patients with Mycobacterium avium bacteremia. J. Clin. Microbiol. 35:2503-2510.[Abstract]
10
10. Shafran, S. D., J. Singer, D. P. Zarowny, P. Phillips, I. Salit, S. L. Walmsley, M. J. Gill, A. R. Rachlis, R. G. Lalonde, M. M. Fanning, C. M. Tsoukas, et al. 1996. A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. N. Engl. J. Med. 335:377-383.[Abstract/Free Full Text]
11
11. Slutsky, A. M., R. D. Arbeit, T. W. Barber, J. Rich, C. F. von Reyn, W. Pieciak, M. A. Barlow, and J. N. Maslow. 1994. Polyclonal infections due to Mycobacterium avium complex in patients with AIDS detected by pulsed-field gel electrophoresis of sequential clinical isolates. J. Clin. Microbiol. 32:1773-1778.[Abstract/Free Full Text]
12
12. von Reyn, C. F., J. N. Maslow, T. W. Barber, J. O. Falkinham III, and R. D. Arbeit. 1994. Persistent colonisation of potable water as a source of Mycobacterium avium infection in AIDS. Lancet 343:1137-1141.[CrossRef][Medline]
13
13. Vose, D. 1996. Quantitative risk analysis: a guide to Monte Carlo simulation modeling. Wiley, Chichester, West Sussex, United Kingdom.

---

Journal of Clinical Microbiology, January 2003, p. 498-499, Vol. 41, No. 1
0095-1137/03/$08.00+0     DOI: 10.1128/JCM.41.1.498-499.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

This article has been cited by other articles:

• Hilborn, E. D., Yakrus, M. A., Covert, T. C., Harris, S. I., Donnelly, S. F., Schmitt, M. T., Toney, S., Bailey, S. A., Stelma, G. N. Jr. (2008). Molecular Comparison of Mycobacterium avium Isolates from Clinical and Environmental Sources. Appl. Environ. Microbiol. 74: 4966-4968 [Abstract] [Full Text]  
• Peppler, M. S., Kuny, S., Nevesinjac, A., Rogers, C., de Moissac, Y. R., Knowles, K., Lorange, M., De Serres, G., Talbot, J. (2003). Strain Variation among Bordetella pertussis Isolates from Quebec and Alberta Provinces of Canada from 1985 to 1994. J. Clin. Microbiol. 41: 3344-3347 [Abstract] [Full Text]  

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kunimoto, D. Y. Articles by Shafran, S. D. Search for Related Content PubMed PubMed Citation Articles by Kunimoto, D. Y. Articles by Shafran, S. D.